• White Twitter Icon
  • White Instagram Icon

POPULAR LINKS:

CONTACT:

P.O. Box 11309

San Bernardino

CA 92374

United States

iccbba@iccbba.org

P: +1 909 793 6516 

F: +1 909 793 6214

ISBT 128  NEWSLETTER

Click on the button below to subscribe to our newsletter.

Copyright © 2019 ICCBBA. All Rights Reserved.

NEWS & ANNOUNCEMENTS

GENERAL NEWS

NEW PRODUCT LOOKUP WEB APPLICATION

05 October 2018

Special Testing General Database

25 Augst 2016

ICCBBA recognizes the growing need for facilities to be able to differentiate their blood component units that have been tested for the Zika virus and found to be non-reactive. A number of facilities have requested guidance recently for the coding and labeling of such units. As a result, ICCBBA has issued new codes that can be encoded into the ISBT 128 Special Testing General Data Structure. This is the same data structure that is commonly used for bar coding the anti-CMV negative test result found in the lower right quadrant of the ISBT 128 blood label.

The Special Testing General Data Structure is intended to indicate special characteristics of a product such as whether it has been phenotyped, the presence of antibodies, CMV antibody status, Hemoglobin S status, etc. Therefore it is fitting to use this data structure to encode Zika negative test results. The codes were added to version 5.3.0 of the Special Testing General Database to represent scenarios anticipated to be commonly used:

  • Test for Zika virus negative

  • CMV seronegative; Test for Zika virus negative

While the testing methodology in the US for the Zika virus is in an investigational status, this may not be the case in other regions of the world, and the transition from an “investigational” status to an “approved” status may also occur at different times. Since the ISBT 128 Standard is an international standard, it is important to note that details of the test methodology and status are not being encoded into these new codes for Zika. Such details may be included in accompanying documentation. In general, the codes found in the Special Testing Database that are related to additional screening/testing do not include testing methodology or status unless otherwise stated in their definition.

Those choosing to use the new codes would need to understand that the verbiage in the Special Testing General Database does not necessarily match the verbiage that is printed on the label. The label text is nationally defined. For example, a commonly used code in the US is N0008 (defined in the Database as “CMV seronegative”); the nationally defined label text for this in the US is “Negative for antibodies to CMV” or “Anti-CMV Neg.” Users should verify the approved label verbiage with their regulator(s) for indicating the negative Zika test result on the label.

Users choosing to optionally bar code the Zika negative test result would need to download the Special Testing General Database from the ICCBBA website. The Database is available to ICCBBA-licensed users at www.iccbba.org/tech-library/iccbba-documents/databases-and-reference-tables/special-testing-general-database. Proper log-in is required to access the download. Any questions regarding the use of the ISBT 128 codes and data structures can be sent to iccbba@iccbba.org.

PRESS RELEASES

2018 ICCBBA ENTERPRISE GRANT RECIPIENT 

30 JULY 2018

ICCBBA is pleased to announce Bloodworks Northwest, a nonprofit organization based in Seattle, Washington, USA, as the recipient of the 2018 ICCBBA Enterprise Grant for its proposal to implement an innovative technological strategy for blood donor recruitment and retention in Webuye, Bungoma County, Western Kenya.

CELL THERAPY AUDIT TOOL 

04 OCTOBER 2017

ICCBBA is pleased to announce the release of a new ISBT 128 compliance audit tool for use with cellular therapy products.

2017 ICCBBA ENTERPRISE GRANT RECIPIENT

08 AUGUST 2017

ICCBBA is pleased to announce Global Healing, a nonprofit organization based in Berkeley, California, USA, as the recipient of the 2017 ICCBBA Enterprise Grant for its proposal to strengthen the quality management system of the blood bank at the Hôpital Universitaire de Mirebalais (HUM) in Haiti.

UPCOMING EVENTS

EBMT 45th ANNUAL MEETING

19 MAR 2019

ICCBBA will be attending EBMT's 45th Annual Meeting from Mar 24th to the 27th in Frankfurt, Germany. 

TCT MEETING (ASBMT/CIBMTR Tandem)

11 FEB 2019

ICCBBA will be attending the TCT Meeting from Feb 20th to the 24th in Houston, Texas. 

EEBA CONGRESS 

01 JAN 2019

ICCBBA will be attending the EEBA Congress from January 17 to the 19th in Rotterdam, Netherlands.